We're available 24/7. Call us anytime. (888) 552-6760
(888) 552-6760 SCHEDULE AN APPOINTMENT

Emmanuel John Mitsinikos,

Urologic Surgeon

Biography photo
Location
Upland
1100 San Bernardino Road, Suite 1100
Upland, CA 91786
Glendora
412 West Carroll Avenue, Suite 200
Glendora, CA 91741
Specialties
Urology and Urologic Oncology
Education
Medical school:
Degrees

  • 2012, Doctor of Medicine, Keck School of Medicine of USC, Los Angeles, CA

  • 2008, Bachelor of Arts, Biological Sciences and Business Administration, Keck School of Medicine of USC, Los Angeles, CA

Residency

  • 2012-2018, Urology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA

Professional Experience

  • 2018-present, Assistant Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery, City of Hope, Upland, CA

Academic Appointments
  • Assistant Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery
About Me
“From a very early age I knew I wanted to help people.”
 
Emmanuel Mitsinikos, M.D., is passionate about finding and employing the latest technologies to give his patients the best possible care. He makes a point of educating patients about all their options, “so they are more readily equipped to make the right decision for themselves.”
 
Dr. Mitsinikos joined City of Hope after six years at Kaiser Permanente Los Angeles Medical Center. He earned his medical degree at Keck School of Medicine of USC.
 
Dr. Mitsinikos takes pride in helping patients return to their normal lives. He has written papers on nerve-sparing surgical techniques which help preserve men's functioning and fertility. He feels City of Hope is a perfect fit, both for its patient-centered care and its reputation for research.
 
“When thinking of leading-edge medical advancement and treatment,” he says, “you don't have to look much further than City of Hope.”
 
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.